Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Performance benefited from expanded sales of the Mighty series, accumulated recurring revenue, the inclusion of ラジエンスウエア株式会社 as a consolidated subsidiary, higher development productivity driven by the use of AI, a shift of resources toward highly skilled personnel, a reduction in the number of engineers, and cost-structure reforms. Meanwhile, quarterly net income declined due to a temporary tax-effect impact.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥1,744 million (YoY +17.5%) |
| Operating profit | ¥410 million (YoY +30.9%) |
| Ordinary income | ¥395 million (YoY +25.0%) |
| Profit attributable to owners of the parent | ¥263 million (YoY -2.9%) |
| Net income per share | ¥21.78 |
| Equity ratio | End of the current fiscal period 69.8 / End of previous period 75.5 |
| Total assets | ¥8,346 million |
| Net assets | ¥5,832 million |
| Full-year earnings forecast | Net Sales ¥7,383 million (YoY +23.2%) / Operating profit ¥1,511 million (YoY +15.9%) / Ordinary income ¥1,520 million (YoY +18.1%) / Net income ¥1,056 million (YoY +18.4%) |
| Annual Dividend Forecast | ¥40 → Not disclosed |
| Segment revenue | Medical Business ¥653,581 thousand (YoY +45.8%), Technology Consulting Business ¥1,090,511 thousand (YoY +5.2%) |
| Segment profit | Medical Business ¥319,384 thousand (YoY +7.2%), Technology Consulting Business ¥183,867 thousand (YoY +57.0%) |
| Depreciation and amortization | ¥52,613 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥14,122 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥264 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name ラジエンスウエア株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 12,249,920 |
| Treasury Shares at Period-End | 126,679 |
| Factors Behind Changes in Business Performance | Performance benefited from expanded sales of the Mighty series, accumulated recurring revenue, the inclusion of ラジエンスウエア株式会社 as a consolidated subsidiary, higher development productivity driven by the use of AI, a shift of resources toward highly skilled personnel, a reduction in the number of engineers, and cost-structure reforms. Meanwhile, quarterly net income declined due to a temporary tax-effect impact. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Medical Business, performance benefited from expanded sales of the Mighty series, accumulated recurring revenue, and the inclusion of ラジエンスウエア株式会社 as a consolidated subsidiary. In the Technology Consulting Business, profitability improved through higher development productivity driven by the use of AI, a shift of resources toward highly skilled personnel, a reduction in the number of engineers, and cost-structure reforms. The company explained that the decline in net income was due to a temporary tax-effect impact.